Delaware County Daily Times Publishes Letter to the Editor

In a significant legislative development, House Bill 1691, Pennsylvania’s version of the False Claims Act, has advanced through the state House with strong bipartisan support on a 136-67 vote. The bill now awaits consideration in the Senate Health and Human Services Committee, positioning Pennsylvania to join numerous other states with similar anti-fraud measures.

The proposed legislation mirrors the federal False Claims Act but extends its reach specifically to fraudulent claims against Pennsylvania state government. While Medicaid fraud would be a primary focus, the bill would also provide mechanisms to combat fraud in state contracts for highway construction, government facilities, service billing, and various other areas where taxpayer dollars may be misappropriated.

At the core of this legislation is the “qui tam” provision—derived from a Latin phrase indicating action “on behalf of themselves and the king”—which enables individuals with firsthand knowledge of fraud to file lawsuits against entities defrauding the government. These plaintiffs often possess insider information about fraudulent activities that would otherwise remain hidden from government oversight.

The process would follow established federal protocols: whistleblowers with evidence of fraud file sealed lawsuits, keeping allegations confidential initially. The Pennsylvania Attorney General would then have 60 days to review evidence and determine whether to intervene. If the state takes over prosecution, the whistleblower assists the government’s case and receives a percentage of any recovered funds as compensation for their role in exposing the fraud.

Critics of the legislation, including Curt Schroder in a recent Daily Times op-ed, have characterized the bill as “a gift to the trial bar” that expands liability and creates opportunities to target private businesses for financial gain. However, supporters counter that such characterizations misrepresent the nature of qui tam suits, which primarily serve to alert authorities to existing fraud rather than create new liabilities.

The federal version of this legislation has proven remarkably effective at recovering taxpayer money. Government agencies recoup billions annually from fraudulent claims, with healthcare fraud alone accounting for approximately $3-4 billion in recoveries when actively prosecuted by U.S. attorneys.

For whistleblowers, pursuing these cases carries substantial personal and professional risks. Many qui tam plaintiffs face career repercussions after coming forward. The most favorable outcome occurs when the government intervenes and successfully prosecutes cases. When whistleblowers must proceed alone after government declination, they face steep challenges, including difficulty securing legal representation due to the uncertain prospects of recovery despite extensive work requirements.

The False Claims Act’s history stretches back to the Civil War era, when it was enacted to combat widespread contractor fraud that supplied Union troops with defective weapons, spoiled food, and inadequate uniforms. Its endurance as a fraud-fighting tool speaks to its effectiveness in protecting public funds from misappropriation.

Pennsylvania’s move to adopt its own version aligns the Commonwealth with the majority of states that have already implemented similar protections for state taxpayer dollars. The legislation represents a potentially significant enhancement to Pennsylvania’s ability to detect and prosecute fraud, particularly at a time when government contracting continues to involve substantial public resources across healthcare, infrastructure, and other essential services.

As HB 1691 progresses through the legislative process, its supporters emphasize that the bill serves primarily as a mechanism for transparency and accountability in government spending rather than an expansion of liability or an invitation for frivolous litigation.